Interleukin-7 in rheumatoid arthritis

Rheumatology

Volumn 47, Issue 6, 2008, Pages 753-759

  Churchman, S M ^a   Ponchel, F ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

IL 7; Inflammation; RA; T cells

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 7; INTERLEUKIN 7 ANTIBODY; INTERLEUKIN 7 RECEPTOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; PREDNISOLONE; RECOMBINANT INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; BONE MASS; CELL MATURATION; CELL PROLIFERATION; CELL SELECTION; CELL SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DENDRITIC CELL; DISEASE ACTIVITY; DRUG RESPONSE; GENE MUTATION; GENE THERAPY; HEPATITIS; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INNATE IMMUNITY; JOINT DESTRUCTION; JUVENILE RHEUMATOID ARTHRITIS; MELANOMA; MONOTHERAPY; NEOPLASM; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UNSPECIFIED SIDE EFFECT; UPREGULATION; VACCINATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE AND BONES; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-7; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MICE; T-LYMPHOCYTES;

EID: 44849125718     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken053     Document Type: Review

References (120)

1. Welch PA, Namen AE, Goodwin RG, Armitage R, Cooper MD. Human Il-7 - a novel T-cell growth factor. J Immunol 1989;143:3562-7.
2. Harada S, Yamamura M, Okamoto H et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 1999;42:1508-16.
3. Hofmeister R, Khaled AR, Benbernou N et al. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev 1999;10:41-60.
4. Fry TJ, Mackall CL. Interleukin-7: From bench to clinic. Blood 2002;99:3892-904.
5. Lee SK, Surh CD. Role of interleukin-7 in bone and T-cell homeostasis. Immunol Rev 2005;208:169-80.
6. Jiang Q, Li WQ, Aiello FB et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005;16:513-33.
7. Ariel A, Hershkoviz R, Cahalon L et al. Induction of T cell adhesion to extracellular matrix or endothelial cell ligands by soluble or matrix-bound interleukin-7. Eur J Immunol 1997;27:2562-70.
8. Clarke D, Katoh O, Gibbs RV, Griffiths SD, Gordon MY. Interaction of interleukin-7 (Il-7) with glycosaminoglycans and its biological relevance. Cytokine 1995;7:325-30.
9. Reche PA, Soumelis V, Gorman DM et al. Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 2001;167:336-43.
10. Quentmeier H, Drexler HG, Fleckenstein D et al. Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation. Leukemia 2001;15:1286-92.
11. Golden-Mason L, Kelly AM, Traynor O et al. Expression of interleukin 7 (IL-7) mRNA and protein in the normal adult human liver: implications for extrathymic T cell development. Cytokine 2001;14:143-51.
12. Madrigal-Estebas L, McManus R, Byrne B et al. Human small intestinal epithelial cells secrete interleukin-7 and differentially express two different interleukin-7 mRNA transcripts: Implications for extrathymic T-cell differentiation. Hum Immunol 1997;58:83-90.
13. Kroncke R, Loppnow H, Flad HD, Gerdes J. Human follicular dendritic cells and vascular cells produce interleukin-7: A potential role for interleukin-7 in the germinal center reaction. Eur J Immunol 1996;26:2541-4.
14. Watanabe M, Ueno Y, Yajima T et al. Interleukin-7 is produced by human intestinal epithelial-cells and regulates the proliferation of intestinal mucosal lymphocytes. Eur J Clin Invest 1995;95:2945-53.
15. Sorg RV, McLellan AD, Hock BD, Fearnley DB, Hart DNJ. Human dendritic cells express functional interleukin-7. Immunobiology 1998;198:514-26.
16. de Saint-Vis, Fugier-Vivier BI, Massacrier C et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J Immunol 1998;160:1666-76.
17. Lee S, Kalinowski JF, Cabrera-Hernandez A et al. Interleukin-7 influences osteoclast and osteoblast function in vivo but is not a critical factor in ovariectomy-induced bone loss. J Bone Miner Res 2003;18:S327.
18. Nutt SL, Heavey B, Rolink AG, Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999;401:556-62.
19. Weitzmann MN, Roggia C, Toraldo G, Weitzmann L, Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 2002;110:1643-50.
20. Miyaura C, Onoe Y, Inada M et al. Increased B-lymphopoiesis by IL-7 treatment induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. J Bone Miner Res 1997;12:93.
21. Weitzmann MN, Cenci S, Rifas L, Brown C, Pacifici R. Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 2000;96:1873-8.
22. Toyosaki-Maeda T, Takano H, Tomita T et al. Differentiation of monocytes into multinucleated giant bone-resorbing cells: Two-step differentiation induced by nurse-like cells and cytokines. Arthritis Res 2001;3:306-10.
23. Takano H, Tomita T, Toyosaki-Maeda T et al. Comparison of the activities of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids of rheumatoid arthritis and osteoarthritis patients. Rheumatology 2004;43:435-41.
24. Peschon JJ, Morrissey PJ, Grabstein KH et al. Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice. J Exp Med 1994;180:1955-60.
25. von Freeden-Jeffry U, Davidson N, Wiler R et al. IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis. J Immunol 1998;161:5673-80.
26. Kee BL, Bain G, Murre C. IL-7R alpha and E47: Independent pathways required for development of multipotent lymphoid progenitors. EMBO J 2002; 21:103-13.
27. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T-B=NK+ severe combined immunodeficiency. Nat Genet 1998;20:394-7.
28. AbdulHai A, Or R, Slavin S et al. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol 1996; 24:1416-22.
29. Ben Yehuda A, Wirtheim E, Abdulhai A et al. Activation of the recombination activating gene 1 (RAG-1) transcript in bone marrow of senescent C57BL/6 mice by recombinant interleukin-7. J Gerontol A-Biol 1999;54:B143-8.
30. Ponchel F, Verburg R, Bingham S et al. IL-7 deficiency and therapy-induced lymphopenia in rheumatoid arthritis. Arthritis Res Ther 2005;7:82-92.
31. Papadaki HA, Kritikos HD, Gemetzi C et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: Evidence for a tumor necrosis factor alpha-mediated effect. Blood 2002;99:1610-9.
32. Sportès C, Gress R. Interleukin-7 immunotherapy. Adv Exp Med Biol 2007; 601:321-33.
33. Goldberg G, Zakrzewski J, Perales M, van den Brink M. Clinical strategies to enhance T cell reconstitution. Semin Immunol 2007;19:289-96.
34. Bielekova B, Muraro PA, Golestaneh L et al. Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7. J Neuroimmunol 1999;100:115-23.
35. Traggiai E, Biagioli T, Rosati E et al. IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis. J Neuroimmunol 2001;121:111-9.
36. Lundmark F, Duvefelt K, Iacobaeus E et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007;39:1108-13.
37. Gregory S, Schmidt S, Seth P et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007;39:1083-91.
38. Dalloul A, Laroche L, Bagot M et al. Interleukin-7 is a growth-factor for Sezary lymphoma cells. J Clin Invest 1992;90:1054-60.
39. Frishman J, Long B, Knospe W, Gregory S, Plate J. Genes for interleukin-7 are transcribed in leukemic-cell subsets of individuals with chronic lymphocytic-leukemia. J Exp Med 1993;177:955-64.
40. Trumper L, Jung W, Dahl G et al. Interleukin-7, interleukin-8, soluble Tnf receptor, and P53 protein-levels are elevated in the serum of patients with Hodgkins disease. Ann Oncol 1994;5:S93-6.
41. Vella AT, Dow S, Potter T, Kappler J, Marrack P. Cytokine induced survival of activated T-cells in vitro and in vivo. Proc Natl Acad Sci USA 1998;95:3810-5.
42. Boise LH, Minn AJ, June CH, Lindsten T, Thompson CB. Growth-factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc Natl Acad Sci USA 1995;92:5491-5.
43. Fry TJ, Christensen BL, Komschlies KL, Gress RE, Mackall CL. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood 2001;97:1525-33.
44. Soares M, Borthwick N, Maini M et al. IL-7 dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naïve repertoire. J Immunol 1998;161:5909-17.
45. Webb LMC, Foxwell BMJ, Feldmann M. Putative role for interleukin-7 in the maintenance of the recirculating naive CD4(+) T-cell pool. Immunology 1999;98:400-5.
46. Brenchley JM, Douek D, Ambrozak DR et al. expansion of activated human naive T-cells precedes effector function. Clin Exp Immunol 2002;130:431-40.
47. Bradley LM, Haynes L, Swain SL. IL-7: Maintaining T-cell memory and achieving homeostasis. Trends Immunol 2005;26:172-6.
48. Bolotin E, Smogorzewska E, Wells W, Weinberg K. Serum level of interleukin-7 (IL-7) is not impaired in infants after thymectomy. Exp Hematol 1998;26:328.
49. Fry TJ, Connick E, Falloon J et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 2001;97:2983-90.
50. Napolitano LA, Grant RM, Deeks SG et al. Increased production of IL-7 accompanies HIV-l-mediated T-cell depletion: Implications for T-cell homeostasis. Nat Med 2001;7:73-9.
51. Fry TJ, Mackall CL. Interleukin-7: Master regulator of peripheral T-cell homeostasis? Trends Immunol 2001;22:564-71.
52. Mazzucchelli R, Durum S. Interleukin-7 receptor expression: Intelligent design. Nat Rev Immunol 2007;7:144-54.
53. Kim H, Hwang K, Kang I. Dual roles of IL-15 in maintaining IL-7R{alpha}lowCCR7 memory CD8+ T cells in humans via recovering the phosphatidylinositol 3-kinase/AKT pathway. J Immunol 2007;179:6734-40.
54. Vranjkovic A, Crawley A, Gee K, Kumar A, Angel J. IL-7 decreases IL-7 receptor {alpha} (CD127) expression and induces the shedding of CD127 by human CD8+ T cells. Int Immunol 2007;19:1329-39.
55. Carrio R, Rolle C, Malek T. Non-redundant role for IL-7R signaling for the survival of CD8(+) memory T cells. Eur J Immunol 2007;37:3078-88.
56. Zúñiga-Pflücker J. CD8+ T cells are kept in tune by modulating IL-7 responsiveness. Nat Immunol 2007;8:1027-8.
57. Boeckh M, Nichols WG, Papanicolaou G et al. Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies. Biol Blood Marrow Transplant 2003;9:543-58.
58. van Roon JAG, Glaudemans K, Bijlsma JWJ, Lafeber F. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:113-9.
59. Stabler T, Piette JC, Chevalier X, Marini-Portugal A, Kraus VB. Serum cytokine profiles in relapsing polychondritis suggest monocyte/ macrophage activation. Arthritis Rheum 2004;50:3663-7.
60. Hitchon CA, Alex P, Erdile LB et al. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. J Rheumatol 2004;31:2336-46.
61. Raza K, Falciani F, Curnow SJ et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005;7:R784-95.
62. de Jager W, Prakken BJ, Bijlsma JWJ, Kuis W, Rijkers GT. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J Immunol Methods 2005;300:124-35.
63. van Roon J, Verweij M, Wenting-van Wijk M et al. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4+ T cells and macrophages. Arthritis Rheum 2005;52:1700-10.
64. Tanabe BK, Abe LM, Kimura LH, Reinker KA, Yamaga KM. Cytokine mRNA repertoire of articular chondrocytes from arthritic patients, infants, and neonatal mice. Rheumatol Int 1996;16:67-76.
65. Leistad L, Ostensen M, Faxvaag A. Detection of cytokine mRNA in human, articular cartilage from patients with rheumatoid arthritis and osteoarthritis by reverse transcriptase polymerase chain reaction. Scand J Rheumatol 1998;27:61-7.
66. Shimaoka Y, Attrep JF, Hirano T et al. Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells. J Clin Invest 1998;102:606-18.
67. Kunisch E, Fuhrmann R, Roth A et al. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 2004;63:774-84.
68. Timmer T, Baltus B, Vondenhoff M et al. Inflammation and ectopic lymphoid structures in rheumatoid arthritis synovial tissues dissected by genomics technology identification of the interleukin-7 signaling pathway in tissues with lymphoid neogenesis. Arthritis Rheum 2007;56:2492-502.
69. Haringman JJ, Gerlag DM, Zwinderman AH et al. Synovial tissue macrophages: A sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:834-8.
70. van Roon JAG, Hartgring SAY, Wenting-van Wijk M et al. Persistence of interleukin 7 activity and levels on tumour necrosis factor {alpha} blockade in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66:664-9.
71. Natsumeda M, Nishiya K, Ota Z. Stimulation by interleukin-7 of mononuclear-cells in peripheral-blood, synovial-fluid and synovial tissue from patients with rheumatoid-arthritis. Acta Med Okayama 1993;47:391-7.
72. Kim K, Lee C, Sayers TJ, Muegge K, Durum SK. The trophic action of IL-7 on pro-T cells: Inhibition of apoptosis of pro-T1, -T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways. J Immunol 1998;160:5735-41.
73. Amos CL, Woetmann A, Nielsen M et al. The role of caspase 3 and Bclx(L) in the action of interleukin 7 (IL-7): A survival factor in activated human T cells. Cytokine 1998;10:662-8.
74. Li WQ, Jiang Q, Khaled AR, Keller JR, Durum SK. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem 2004;279:29160-6.
75. Burgoyne CH, Field SL, Brown AK et al. Abnormal T-cell differentiation persists in rheumatoid arthritis patients in clinical remission and predicts relapse. Ann Rheum Dis 2007, doi:10.1136/ ard.2007.073833, in Press.
76. Rathmell JC, Farkash EA, Gao W, Thompson CB. IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 2001;167:6869-76.
77. Barata JT, Cardoso AA, Nadler LM, Boussiotis VA. Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p(27kip1). Blood 2001;98:1524-31.
78. Barata JT, Silva A, Brandao JG et al. Activation of P13K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med 2004;200:659-69.
79. Kitas GD, Salmon M, Farr M, Gaston JSH, Bacon PA. Deficient interleukin-2 production in rheumatoid arthritis - association with active disease and systemic complications. Clin Exp Immunol 1988;73:242-9.
80. Maurice N, Makumura H, van der Voort E. Evidence for the role of altered red/ox state in hyporesponsiveness of synovial T-cells in RA. J Immunol 1997;158:1458-65.
81. Allen ME, Young SP, Michell RH, Bacon PA. Altered T-lymphocyte signaling in rheumatoid-arthritis. Eur J Immunol 1995;25:1547-54.
82. Emery P, Panayi GS, Nouri AME. Interleukin-2 reverses deficient cell-mediated immune-responses in rheumatoid arthritis. Clin Exp Immunol 1984;57:123-9.
83. Marquez C, Trigueros C, Fernandez E, Toribio ML. The development of T-cell and non-T-cell lineages from Cd34(+) human thymic precursors can be traced by the differential expression of Cd44. J Exp Immunol 1995;181:475-83.
84. Varas A, Vicente A, Sacedon R, Zapata AG. Interleukin-7 influences the development of thymic dendritic cells. Blood 1998;92:93-100.
85. Gringhuis SI, deLeij L, Verschuren EW, Borger P, Vellenga E. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. Blood 1997;90:2690-700.
86. Mehrotra PT, Grant AJ, Siegel JP. Synergistic effects of Il-7 and Il-12 on human T-cell activation. J Immunol 1995;154:5093-102.
87. Borger P, Kauffman HF, Postma DS, Vellenga E. IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J Immunol 1996;156:1333-8.
88. Skapenko A, Wendler J, Lipsky P, Kalden J, Schulze-Koops H. Altered memory T-cell differentiation in patients with early rheumatoid arthritis. J Immunol 1999;163:491-9.
89. Skapenko A, Niedobitek GU, Kalden JR, Lipsky PE, Schulze-Koops H. Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol 2004;172:6427-34.
90. Chakir H, Wang HP, Lefebvre DE, Webb J, Scott FW. T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3. J Immunol Methods 2003;278:157-69.
91. Kawashima M, Miossec P. mRNA quantification of T-bet, GATA-3, IFN-gamma, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: Link with disease activity. J Clin Immunol 2005;25:209-14.
92. Ponchel F, Brown AK, Field SL et al. T-bet expression in RA patients with early, DMARDs naive disease is low and correlates with low levels of IL-7 and T-cell dysfunctions. Arthritis Rheum 2004;50:S525.
93. van Roon JAG, Glaudemans CA, Bijlsma JWJ, Lafeber F. Differentiation of naive CD4(+) T cells towards T helper 2 cells is not impaired in rheumatoid arthritis patients. Arthritis Res Ther 2003;5:R269-76.
94. Brennan FM, Hayes AL, Ciesielski CJ et al. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells - involvement of phosphatidylinositol 3-kinase and nuclear factor kappa B pathways in tumor necrosis factor a production in rheumatoid arthritis. Arthritis Rheum 2002;46:31-41.
95. Ponchel F, Morgan AW, Bingham SJ et al. Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood 2002;100:4550-6.
96. Unumtaz D, Pileri P, Abrignani S. Antigen-independent activation of naïve and memory resting T-cells by a cytokine combination. J Exp Med 1994;180:1159-64.
97. Unutmaz D, Baldoni F, Abrignani S. Human naive T-cells activated by cytokines differentiate into a split phenotype with functional features intermediate between naive and memory T-cells. Int Immunol 1995;7:1417-24.
98. Meier D, Bornmann C, Chappaz S et al. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 2007;26:643-54.
99. Debenedetti F, Massa M, Pignatti P et al. Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid-arthritis. J Rheumatol 1995; 22:1581-5.
100. Churchman SM, Field SL, Burgoyne CH et al. Circulating levels of IL-7 in RA. Rheumatology 2007;46:i45.
101. Teutsch S, Booth D, Bennetts B, Heard R, Stewart G. Identification of 11 novel and common single nucleotide polymorphisms in the interleukin-7 receptor-alpha gene and their associations with multiple sclerosis. Eur J Hum Genet 2003; 11:509-15.
102. Shamim Z, Müller K, Svejgaard A et al. Association between genetic polymorphisms in the human interleukin-7 receptor alpha-chain and inhalation allergy. Int J Immunogenet 2007;34:149-51.
103. Shamim Z, Ryder L, Heilmann C et al. Genetic polymorphisms in the genes encoding human interleukin-7 receptor-alpha: Prognostic significance in allogeneic stem cell transplantation. Bone Marrow Transplant 2006;37:485-91.
104. Jo E, Kook H, Uchiyama T et al. Characterization of a novel nonsense mutation in the interleukin-7 receptor alpha gene in a Korean patient with severe combined immunodeficiency. Int J Hematol 2004;80:332-5.
105. Song H, Nakayama E, Likanonsakul S et al. A three-base-deletion polymorphism in the upstream non-coding region of human interleukin 7 (IL-7) gene could enhance levels of IL-7 expression. Int J Immunogenet 2007;34:107-13.
106. Moller P, Sun Y, Dorbic T et al. Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: A clinical phase I study. Br J Cancer 1998;77:1907-16.
107. Sawa S, Kamimura D, Jin GH et al. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/ IL-7-dependent homeostatic proliferation of CD4(+) T cells. J Exp Med 2006;203:1459-70.
108. Hartgring SAY, Bijlsma JWJ, Lafeber F, van Roon JAG. Interleukin-7 induced immunopathology in arthritis. Ann Rheum Dis 2006;65:69-74.
109. Watanabe M, Watanabe N, Iwao Y et al. The serum factor from patients with ulcerative colitis that induces T cell proliferation in the mouse thymus is interleukin-7. J Clin Immunol 1997;17:282-92.
110. Routy JP, Boulassel MRR, Conway B, Sekaly RP. Alteration of the IL-7 homeostatic response to T-cell depletion during the course of HIV-infection is independent of viremia. Blood 2001;98:501A.
111. Szepietowski JC, Bielicka E, Nockowski P, Noworolska A, Wasik F. Increased interleukin-7 levels in the sera of psoriatic patients: Lack of correlations with interleukin-6 levels and disease intensity. Clin Exp Dermatol 2000;25:643-7.
112. Darcissac ECA, Vidal V, De La Tribonniere X, Mouton Y, Bahr GM. Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy. Clin Exp Immunol 2001;126:287-94.
113. Xie X, Ye D, Chen H et al. Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma. Int J Gynecol Obstet 2004;85:151-8.
114. Ruprecht CR, Gattorno M, Ferlito F et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 2005; 201:1793-803.
115. Cox AL, Thompson SAJ, Jones JL et al. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur J Immunol 2005;35:3332-42.
116. Wasilewska A, Zoch-Zwierz WM, Tomaszewska B, Zelazowska B. Relationship of serum interleukin-7 concentration and the coagulation state in children with nephrotic syndrome. Pediatr Int 2005;47:424-9.
117. Fernandez S, Nolan RC, Price P et al. Thymic function in severely immunodeficient HIV type 1-infected patients receiving stable and effective antiretroviral therapy. AIDS Res Hum Retroviruses 2006;22:163-70.
118. Llano A, Barretina J, Gutierrez A, Clotet B, Este JA. Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression. J Virol 2003;77:4389-95.
119. Kang I, Hong MS, Nolasco H et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 2004;173:673-81.
120. Carratelli CR, Nuzzo I, Cozzolino D et al. Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases. Int Immunopharmacol 2006;6:848-53.